<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BEAM
Beam Therapeutics
$
()


  • Citi sees limited readthrough for Beam Therapeutics from VERVE-101 trial pause

    4/2/2024 - 19:14pm
  • Korro Bio price target raised by $15 at H.C. Wainwright, here's why

    3/28/2024 - 06:12am
  • Beam Therapeutics' clinical trial of BEAM-302 in AATD cleared in the UK

    3/26/2024 - 06:37am
  • Beam Therapeutics price target raised by $8 at RBC Capital, here's why

    2/28/2024 - 07:50am
  • Beam Therapeutics files automatic mixed securities shelf

    2/28/2024 - 06:13am
  • Beam Therapeutics price target raised by $16 at Barclays, here's why

    2/28/2024 - 05:23am
  • Beam Therapeutics reports Q4 EPS $1.73, consensus ($1.01)

    2/27/2024 - 06:33am
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    1/30/2024 - 13:15pm
  • Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

    1/30/2024 - 10:55am
  • Beam Therapeutics just upgraded at JPMorgan, here's why

    1/29/2024 - 05:02am
  • Beam Therapeutics price target lowered by $29 at Stifel, here's why

    1/15/2024 - 14:25pm
  • The Smid-cap biotech stocks to own in 2024, according to Bernstein

    1/2/2024 - 11:19am
  • BofA downgrades Beam Therapeutics, thinks shares may 'trade sideways'

    12/15/2023 - 08:29am
  • BofA gets more bearish on Beam Therapeutics, downgrades shares

    12/15/2023 - 07:37am
  • Qualcomm downgraded, First Solar upgraded: Wall Street's top analyst calls

    12/8/2023 - 09:30am
dynamic_feed Breaking News